共 50 条
Locked nucleic acids (LNA) and medical applications
被引:0
|作者:
Henrik Ørum
Andreas Wolter
Lars Kongsbak
机构:
[1] Bøgealle 3,Santaris Pharma A/S.
[2] Georg-Heyken-Str,Proligo GmbH
[3] Exiqon A/S,undefined
来源:
Letters in Peptide Science
|
2003年
/
10卷
关键词:
affinity;
antisense;
biodistribution;
capture probes;
cellular uptake;
detection-by-hybridisation;
LNA primers;
Locked Nucleic Acids (LNA);
multiplex PCR;
nuclease resistance;
RNaseH recruiment;
specificity;
toxicity;
D O I:
暂无
中图分类号:
学科分类号:
摘要:
Locked Nucleic Acid (LNA) is a novel, third generation DNA analogue that has the potentialto impact strongly on the future development of a diversity of nucleic acid based technologies.The present chapter reviews the known biochemical properties of LNA and exemplifies how thesehave been used to improve both DNA diagnostic technologies and antisense therapeutics.
引用
收藏
页码:325 / 334
页数:9
相关论文